Mike Cloonan
Chief Business Officer
Neurology
Sage Therapeutics
United States of America
Biography
Mike Cloonan joined Sage as Chief Business Officer in April 2017 and leads the Commercial, Portfolio and Program Management, Medical Affairs, and Corporate Development departments. Previously, he served as Senior Vice President, US Commercial, at Biogen where he led the US affiliate with direct general manager responsibility for Sales, Marketing, Market Access, Patient Services and Commercial Operations. During Mike’s 14-year tenure at Biogen, he held roles of increasing responsibility, including Senior Vice President, Global Commercial Strategy; Vice President, Managing Director, Australia/New Zealand affiliate; and Vice President, Business Planning. Prior to Biogen, he worked at Bain & Company as a consultant specializing in healthcare. Mike earned his M.B.A. from Darden Graduate School of Business Administration, University of Virginia and a B.A. from College of the Holy Cross.
Research Interest
medical affairs, neuroscience, Sales, Marketing, Market Access, Patient Services and Commercial Operations.